Sagard NewGen Announces Minority Investment in Quipment

McDermott Will & Schulte has advised Sagard NewGen. Sagard NewGen has completed a minority investment in Quipment, a prominent provider of equipment solutions for clinical trials,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here